--- title: "Neoadjuvant Hodgkin Lymphoma COG AHOD2131 | Sutter Health" description: "A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma" url: "https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. Neoadjuvant Hodgkin Lymphoma COG AHOD2131 # Neoadjuvant Hodgkin Lymphoma COG AHOD2131 **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05675410). #### Locations - Sacramento #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma ![Sandra K Baril, M.D.](https://dyn.mktgcdn.com/p/LeDczJiBVc-OKMwdWQTzaO-WX-HJKEXWeWf47e1fMY4/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Sandra K Baril, M.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/sandra-k-baril-md-2016036488) ## Sub-Investigators [Yung Soon Yim, M.D.](https://www.sutterhealth.org/research/investigators/yung-soon-yim-md-1049681052) , [Saunders C Hsu, M.D., MPH](https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145) , [Rachel Bito, M.D.](https://www.sutterhealth.org/research/investigators/rachel-bito-md-2070392186) ## Email us to enroll - [Email Sacramento](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Neoadjuvant%20Hodgkin%20Lymphoma%20COG%20AHOD2131%20in%20Sacramento&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Cancer Young Female Adults Ovarian Damage Prevention ALTE2131](https://www.sutterhealth.org/research/clinical-trials/cancer-young-female-adults-ovarian-damage-prevention-alte2131-2027477841) Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer **Status:** Open to Enrollment - Clinical trial ### [Pediatric B-Lymphoblastic Leukemia COG AALL1732](https://www.sutterhealth.org/research/clinical-trials/cogaall1732-1049141808) A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLyLy **Status:** Open to Enrollment - Clinical trial ### [Pediatric Cancer Project Every Child APEC14B1](https://www.sutterhealth.org/research/clinical-trials/pediatric-cancer-project-every-child-apec14b1-1049141838) The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study **Status:** Open to Enrollment - Clinical trial ### [Pediatric Long Term Follow Up ALTE05N1](https://www.sutterhealth.org/research/clinical-trials/cogalte05n1-1049141846) Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies **Status:** Open to Enrollment - Clinical trial ### [Advanced Cervical Cancer NRG GY037](https://www.sutterhealth.org/research/clinical-trials/advanced-cervical-cancer-nrg-gy037-2097344123) A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer **Status:** Open to Enrollment [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Neoadjuvant Hodgkin Lymphoma COG AHOD2131"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103#medicalwebpage","name":"Neoadjuvant Hodgkin Lymphoma COG AHOD2131","description":"A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma","url":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103","inLanguage":"en-US","dateModified":"2026-08-11","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103#breadcrumblist"},"mentions":[{"@type":"Person","name":"Sandra K Baril, M.D.","url":"https://www.sutterhealth.org/research/investigators/sandra-k-baril-md-2016036488","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103#medicaltrial","name":"Neoadjuvant Hodgkin Lymphoma COG AHOD2131","alternateName":"A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma","url":"https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103","description":"A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma","identifier":"NCT05675410","code":{"@type":"MedicalCode","codeValue":"NCT05675410","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT05675410","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Lymphoma, Pediatric"}],"studyLocation":[{"@type":"AdministrativeArea","name":"Sacramento"}]} ```